Laura Cosmai
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
A nephrology perspective on the clinical impact and management of delayed high-dose methotrexate elimination.
Journal: Expert review of anticancer therapy
Published: May 26, 2026
Dialisi peritoneale: perché il futuro della nefrologia passa da casa
Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
Published: May 17, 2026
Raccogliere un'eredità e aprire nuove prospettive
Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
Published: April 27, 2026
Tempistica e Durata delle Visite Nefrologiche in Italia
Journal: Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia
Published: April 27, 2026
Multimodal predictions of end stage chronic kidney disease from asymptomatic individuals for discovery of genomic biomarkers.
Journal: BMC nephrology
Published: February 23, 2026
Discovering Predictive Biomarkers in Renal Cell Carcinoma.
Journal: European urology oncology
Published: February 17, 2026
Onco-nephrology in kidney transplant recipients: challenges and evolving strategies.
Journal: Frontiers in immunology
Published: December 31, 2025
Comparative and Critical Analysis of Immune-based Combinations for First-line Treatment of Metastatic Renal Cell Carcinoma.
Journal: Clinical genitourinary cancer
Published: December 15, 2025
The nephrotoxic effects of anti-cancer therapies: consensus report of the 34th Acute Disease Quality Initiative workgroup.
Journal: Nature reviews. Nephrology
Published: October 24, 2025
Conventional cytotoxic chemotherapy-associated nephrotoxicity: consensus report of the 34th Acute Disease Quality Initiative (ADQI) Workgroup.
Journal: Kidney international
Published: September 09, 2025
Conventional cytotoxic chemotherapy-associated nephrotoxicity.
Journal: Kidney international
Published: September 09, 2025
Multidisciplinary therapy managements in endometrial and renal cancer patients treated with pembrolizumab and lenvatinib: a virtuous circle between oncologists and organ specialists.
Journal: Critical reviews in oncology/hematology
Published: May 27, 2025
Last Updated: 09/26/2026